HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Submit a response Services Email this article to a friend Alert me to new issues of the journal

© RSNA, 2008

Symptomatic Uterine Fibroids: Treatment with Uterine Artery Embolization or Hysterectomy—Results from the Randomized Clinical Embolisation versus Hysterectomy (EMMY) Trial

Table E1. Baseline and Procedural Characteristics

Note.—SD = standard deviation.

* Unless otherwise indicated, data are numbers of patients, with percentages in parentheses.

Table E2. Quality of Life Change Scores Up to 2 Years after UAE (n = 81) or Hysterectomy (n = 75)

Note.—Numbers in bold indicate a statistically significant (P < .05) change from baseline in the within-group analysis. EuroQOL-5 = EuroQOL 5 dimension, 3 level version, HUI-3 = Health Utilities Index Mark 3 (HUI-3), Hyst = hysterectomy, MOS = medical outcome study.

*IIQ was only filled out by patients who had incontinence problems at that time.

Table E3. Changes in Self-reported Quality of Urinary and Defecation Function Up to 2 Years after UAE (n = 81) or Hysterectomy (n = 75) Compared to Baseline

Note.—Data are numbers of patients. Hyst = hysterectomy.

Table E4. Table E4. Use of Urinary Incontinence Pads and Medication for Constipation at Baseline and Up to 2 Years after UAE (n = 81) or Hysterectomy (n = 75)

Note.—Data are numbers of patients. P value in bold indicates statistical significance. Hyst = hysterectomy.

This Article Abstract Full Text Submit a response Services Email this article to a friend Alert me to new issues of the journal